Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-10

Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches [Phase 3]

View source ↗

Summary

Phase 3 trial comparing topiramate to placebo for preventing chronic migraine headaches has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Migraine | Phase 3 | Status: COMPLETED